@entity5142 associated with XXXX .

@entity1 @entity1333 @entity262 @entity515 @entity2883 @entity850 @entity5142
OBJECTIVE: To evaluate the outcomes of @entity5142 in @entity1 with @entity2883 . STUDY DESIGN: Retrospective chart review. METHODS: A retrospective chart review was undertaken to review all @entity1 evaluated in an otolaryngology-head and neck surgery department between 1993 and 2001 for active symptoms attributed to @entity5142 who had undergone cytoplasmic staining antineutrophil cytoplasm antibody and perninuclear staining antineutrophil cytoplasm antibody testing and who had a clinical diagnosis of @entity2883 . RESULTS: Twenty-seven @entity1 were identified with @entity2883 and @entity5142 . Among these, 11 of 27 (40.7%) underwent tracheotomy; 13 of 27 (48.1%) required multiple surgical procedures. A history of open laryngotracheal repair was present in 7 of 27 @entity1 (25.9%). @entity515 laser resection and dilation was used in 12 of 27 @entity1 (44.4%). Three of 27 @entity1 (11.1%) had a tracheotomy at last follow-up. @entity1 were followed for an average duration of 76.8 months (6.4 y) from the onset of symptoms attributed to @entity5142 . All @entity1 who underwent open laryngotracheal reconstruction had successful decannulation. CONCLUSIONS: @entity2883 is a @entity1333 that can involve the subglottis. Our approach to airway management in these @entity1 involves a tracheotomy if obstruction occurs during acute inflammatory activity. We recommend minimizing airway manipulation during episodes of @entity262 activity. Once control of the disease process is obtained, consideration is given to either an endoscopic or an open approach based on the extent of @entity850 . Either laryngotracheal reconstruction or @entity515 laser resection and dilation may be undertaken with safety and should result in favorable outcomes.
